產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 細(xì)胞株的表達(dá)量越高越好嗎?
- 偏頭痛治療靶點(diǎn)——CGRP與藥篩細(xì)胞模型
- 4-1BB(CD137)靶點(diǎn)藥物篩選模型
- ATCC細(xì)胞株開(kāi)發(fā)的四階段簡(jiǎn)介
- PD-1/PD-L1:研發(fā)過(guò)剩還是大有可為
- PIM-1激酶抑制劑細(xì)胞篩選模型
- 有關(guān)腫瘤細(xì)胞的基因突變研究講解
- 從《指導(dǎo)原則》中分析參考品盤(pán)設(shè)計(jì)
- 分子診斷標(biāo)準(zhǔn)品,匠心出品,免費(fèi)申領(lǐng)
- GLP-1R、GCGR、GIPR多靶點(diǎn)激動(dòng)劑與代謝疾病
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73309BCR-ABL1 I502L/BaF3

- 詳細(xì)內(nèi)容
CBP73309 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [I502L]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
III. Representative Data | |
1.WB of BCR-ABL1 [I502L]/BaF3 | |
2.Sanger of BCR-ABL1 [I502L]/BaF3 Figure 2. BCR-ABL1 [I502L]/BaF3 I502L Figure 3. BCR-ABL1 [I502L]/BaF3 Fusion | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 I502L Cells (C2). | |